ANTISENSE-BASED EXON SKIPPING AS A THERAPY FOR DUCHENNE MUSCULAR DYSTROPHY, STATUS AND PROSPECTS

被引：0

作者：

van Ommen, G. -J. ^{[1
]}

Aartsma-Rus, A. ^{[1
]}

Evers, M. ^{[1
]}

van Roon, W. ^{[1
]}

'tHoen, P. -B. ^{[1
]}

Kemaladewi, D. ^{[1
]}

Verbeek, S. ^{[1
]}

Yllmaz-Elis, S. ^{[1
]}

Dauwerse, H. ^{[2
]}

Lesnik-Oberstein, S. ^{[2
]}

den Dunnen, J. T. ^{[1
]}

Goemans, N. ^{[3
]}

Tulinus, M. ^{[4
]}

Verschuuren, J. ^{[5
]}

de Kimpe, S. ^{[6
]}

Campion, G. ^{[6
]}

van Deutekom, J. ^{[6
]}

机构：

[1] Leiden Univ, Dept Human Genet, Med Ctr, NL-2300 RA Leiden, Netherlands

[2] Leiden Univ, Dept Clin Genet, Med Ctr, Leiden, Netherlands

[3] Univ Hosp Leuven, Dept Pediat Neurol, Louvain, Belgium

[4] Univ Gothenburg, Dept Pediat, Gothenburg, Sweden

[5] Leiden Univ, Dept Neurol, Med Ctr, Leiden, Netherlands

[6] Prosensa Therapeut, Leiden, Netherlands

来源：

EUROPEAN JOURNAL OF NEUROLOGY | 2011年 / 18卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：7 / 7

页数：1

共 50 条

[41] Clinical trials of exon skipping in Duchenne muscular dystrophy
Mendell, Jerry R.
Sahenk, Zarife
Rodino-Klapac, Louise R.
EXPERT OPINION ON ORPHAN DRUGS, 2017, 5 (09): : 683 - 690
[42] Optimization of Antisense Oligonucleotide Drugs for Skipping Dystrophin Exon 51 and 53 in Duchenne Muscular Dystrophy
Wu, Bo
MOLECULAR THERAPY, 2018, 26 (05) : 148 - 148
[43] Questions about efficacy of exon-skipping therapy for duchenne muscular dystrophy
Poduri, Annapurna
Salih, Mustafa
Walsh, Christopher A.
ANNALS OF NEUROLOGY, 2014, 75 (02) : 326 - 326
[44] Moving towards successful exon-skipping therapy for Duchenne muscular dystrophy
Nakamura, Akinori
JOURNAL OF HUMAN GENETICS, 2017, 62 (10) : 871 - 876
[45] Moving towards successful exon-skipping therapy for Duchenne muscular dystrophy
Akinori Nakamura
Journal of Human Genetics, 2017, 62 : 871 - 876
[46] Targeted exon skipping as a potential gene correction therapy for Duchenne muscular dystrophy
Aartsma-Rus, A
Bremmer-Bout, M
Janson, AAM
den Dunnen, JT
van Ommen, GJB
van Deutekom, JCT
NEUROMUSCULAR DISORDERS, 2002, 12 : S71 - S77
[47] Pip peptide conjugates of exon skipping PMO for therapy of Duchenne muscular dystrophy
Arzumanov, Liz O'Donovan Andrey A.
Gait, Michael J.
HUMAN GENE THERAPY, 2014, 25 (11) : A13 - A14
[48] Dual exon skipping in myostatin and dystrophin as a potential therapy for Duchenne muscular dystrophy
Kemaladewi, D. U.
Hoogaars, W. M. H.
van Heiningen, S. H.
van Deutekom, J. C. T.
den Dunnen, J. T.
van Ommen, G. J. B.
Aartsma-Rus, A. R.
ten Dijke, P.
't Hoen, P. A. C.
NEUROMUSCULAR DISORDERS, 2009, 19 (8-9) : 577 - 577
[49] Predictors of requiring port-a-cath placement in boys with Duchenne muscular dystrophy on antisense oligonucleotide exon skipping therapy
Wright, S.
NEUROMUSCULAR DISORDERS, 2023, 33 : S174 - S174
[50] Less is more: therapeutic exon skipping for Duchenne muscular dystrophy
Aartsma-Rus, Annemieke
van Ommen, Gert-Jan B.
LANCET NEUROLOGY, 2009, 8 (10): : 873 - 875

← 1 2 3 4 5 →